Provided by Tiger Trade Technology Pte. Ltd.

Kazia Therapeutics Limited

11.01
-0.8700-7.32%
Post-market: 11.150.1400+1.27%19:30 EDT
Volume:374.29K
Turnover:4.17M
Market Cap:154.22M
PE:-1.61
High:11.75
Open:11.75
Low:10.83
Close:11.88
52wk High:17.40
52wk Low:4.86
Shares:14.01M
Float Shares:11.66M
Volume Ratio:1.18
T/O Rate:3.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.8190
EPS(LYR):-12.3849
ROE:-106.90%
ROA:-25.70%
PB:4.64
PE(LYR):-0.89

Loading ...

Kazia Therapeutics Announces First Patient Dosed in Pnoc035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric at/Rt Brain Cancer

THOMSON REUTERS
·
Sep 09

Kazia Therapeutics Reports Preclinical Tumor Reduction in Colorectal Cancer Study

MT Newswires Live
·
Sep 01

Kazia Therapeutics - Paxalisib Monotherapy Reduced Tumor Burden; Addition of Pembrolizumab Drove Further Reduction

THOMSON REUTERS
·
Sep 01

Kazia Therapeutics - Phase 2 Trial Enrollment Expected to Begin Q1 2027, Full Enrollment by End of 2027

THOMSON REUTERS
·
Sep 01

Kazia Therapeutics - Plans Five-Arm Phase 2 Trial of Paxalisib Monotherapy and Combination with Pembrolizumab

THOMSON REUTERS
·
Sep 01

Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant Mss/Pmmr Colorectal Cancer and Enhances Response to Immunotherapy

THOMSON REUTERS
·
Sep 01

Kazia Expands Paxalisib Trial into Hr+/her2- Advanced Breast Cancer

Reuters
·
Sep 01

Kazia Therapeutics Expands Paxalisib Clinical Trial into Hr+/Her2- Breast Cancer, Supported by Preclinical Data Showing Strong Clinical Activity and Safety in Hr+ Breast Cancer

THOMSON REUTERS
·
Sep 01

Kazia Therapeutics - Clinical Updates Expected Throughout 2027, Full Readout Anticipated in 2028

THOMSON REUTERS
·
Sep 01

Kazia Therapeutics Limited Announces Oversubscribed Closing of up to $120 Million Public Offering

THOMSON REUTERS
·
Sep 01

Kazia Therapeutics - Files for Offering of 95,110 American Depositary Shares Representing 47,555,000 Ordinary Shares - SEC Filing

THOMSON REUTERS
·
Aug 31

Kazia Therapeutics Launches Registered Public Offering of ADSs and Warrants

Reuters
·
Aug 31

U.S. Stocks on the MOVE-Halliburton, BioNTech, Kazia Therapeutics

Reuters
·
Aug 29

Analysts Offer Insights on Healthcare Companies: Healthequity (HQY), Kazia Therapeutics (KZIA) and Cerus (CERS)

TIPRANKS
·
Aug 28

Kazia Therapeutics Limited Announces Pricing of up to $120 Million Public Offering

THOMSON REUTERS
·
Aug 28

Kazia Therapeutics Ltd: Files to Offer up to $80 Mln of American Depositary Shares Representing Ordinary Shares- SEC Filing

THOMSON REUTERS
·
Aug 28

Kazia Slides After Breast Cancer Drug Update, Equity Offering Launch

Reuters
·
Aug 28

Kazia Therapeutics reports 100% clinical benefit rate in breast cancer treatment

TIPRANKS
·
Aug 28

Kazia Therapeutics announces offering of ADS, warrants

TIPRANKS
·
Aug 28

Kazia Therapeutics Launches Tranched Registered Public Offering of ADSs, Warrants

Reuters
·
Aug 28